sorafenib has been researched along with apilimod in 3 studies
Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (apilimod) | Trials (apilimod) | Recent Studies (post-2010) (apilimod) |
---|---|---|---|---|---|
6,520 | 730 | 5,251 | 32 | 4 | 25 |
Protein | Taxonomy | sorafenib (IC50) | apilimod (IC50) |
---|---|---|---|
1-phosphatidylinositol 3-phosphate 5-kinase | Homo sapiens (human) | 0.0078 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 3 (100.00) | 2.80 |
Authors | Studies |
---|---|
Bharate, SB; Raghuvanshi, R | 1 |
Caballero, E; García-Cárceles, J; Gil, C; Martínez, A | 1 |
Laufer, S; Pillaiyar, T | 1 |
2 review(s) available for sorafenib and apilimod
Article | Year |
---|---|
Kinase Inhibitors as Underexplored Antiviral Agents.
Topics: Animals; Antiviral Agents; Drug Repositioning; Humans; Protein Kinase Inhibitors; Virus Diseases; Viruses | 2022 |
Kinases as Potential Therapeutic Targets for Anti-coronaviral Therapy.
Topics: Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Humans; Protein Kinase Inhibitors; SARS-CoV-2; Signal Transduction; Virus Replication | 2022 |
1 other study(ies) available for sorafenib and apilimod
Article | Year |
---|---|
Recent Developments in the Use of Kinase Inhibitors for Management of Viral Infections.
Topics: Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Drug Approval; Drug Repositioning; High-Throughput Screening Assays; Humans; Protein Kinase Inhibitors; SARS-CoV-2; United States; United States Food and Drug Administration; Virus Diseases | 2022 |